Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) EBITDA (2017 - 2026)

Si-Bone has reported EBITDA over the past 10 years, most recently at -$4.6 million for Q1 2026.

  • For Q1 2026, EBITDA rose 28.1% year-over-year to -$4.6 million; the TTM value through Mar 2026 reached -$16.5 million, up 37.67%, while the annual FY2025 figure was -$18.3 million, 40.87% up from the prior year.
  • EBITDA for Q1 2026 was -$4.6 million at Si-Bone, down from -$1.6 million in the prior quarter.
  • Over five years, EBITDA peaked at -$1.6 million in Q4 2025 and troughed at -$18.6 million in Q2 2022.
  • A 5-year average of -$9.3 million and a median of -$10.0 million in 2023 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: crashed 43.14% in 2022 and later soared 66.89% in 2025.
  • Year by year, EBITDA stood at -$11.1 million in 2022, then rose by 0.86% to -$11.0 million in 2023, then skyrocketed by 56.08% to -$4.8 million in 2024, then soared by 66.89% to -$1.6 million in 2025, then plummeted by 190.56% to -$4.6 million in 2026.
  • Business Quant data shows EBITDA for SIBN at -$4.6 million in Q1 2026, -$1.6 million in Q4 2025, and -$4.5 million in Q3 2025.